{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:25:15Z","timestamp":1760783115349},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir. J. Med. Sc."],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1007\/bf02944350","type":"journal-article","created":{"date-parts":[[2009,1,10]],"date-time":"2009-01-10T03:04:52Z","timestamp":1231556692000},"page":"248-250","source":"Crossref","is-referenced-by-count":9,"title":["The value of metastatic screening in early primary breast cancer"],"prefix":"10.1007","volume":"168","author":[{"given":"M. C.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G. K.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02944350_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM197708112970603","volume":"297","author":"F. H. Gerber","year":"1977","unstructured":"Gerber, F. H., Goodreau, J. J., Kirchner, P. T., Fouty, W. J. Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma. NEJM 1977; 297: 300\u2013303.","journal-title":"NEJM"},{"key":"BF02944350_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0936-6555(05)81165-3","volume":"3","author":"R. Glynne-Jones","year":"1991","unstructured":"Glynne-Jones, R., Young, T., Ahmed, A., Ell, P. J., Berry, R. J. How far investigation for occult metastases in breast cancer aid the clinician. Clinical Oncology 1991; 3: 65\u201372.","journal-title":"Clinical Oncology"},{"key":"BF02944350_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0","volume":"46","author":"E. F. Scanlon","year":"1980","unstructured":"Scanlon, E. F., Oviedo, M. A., Cunningham, M. P., Caprini, J., Khandekar, J. D., Cohen, E., Robinson, B., Stein, E. Preoperative and follow-up procedures on patients with breast cancer. Cancer 1980; 46: 977\u20139.","journal-title":"Cancer"},{"key":"BF02944350_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(96)02133-2","volume":"348","author":"A. P. Forrest","year":"1996","unstructured":"Forrest, A. P., Stewart, H. J., Everington, D., Prescott, R. J., McArdle, C. S., Harnett, A. N., Smith, D. C., Geroge, W. D. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996; 348: 708\u201313.","journal-title":"Lancet"},{"key":"BF02944350_CR5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0095-4543(21)00611-4","volume":"19","author":"C. G. Berman","year":"1992","unstructured":"Berman, C. G., Clark, R. A. Diagnostic imaging in cancer. Primary Care 1992; 19: 677\u2013713.","journal-title":"Primary Care"},{"key":"BF02944350_CR6","first-page":"991","volume":"5","author":"D. Hadley","year":"1998","unstructured":"Hadley, D., Fowble, B., Torosian, M. H. Evidence of selective use of bone scans in early stage breast cancer. Oncol. Rep. 1998, 5: 991\u20133.","journal-title":"Oncol. Rep."},{"key":"BF02944350_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9610(05)80512-4","volume":"165","author":"H. S. Brar","year":"1993","unstructured":"Brar, H. S., Sisley, J. F., Johnson, R. H. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients. Am. J. Surg. 1993; 165: 221\u2013223.","journal-title":"Am. J. Surg."},{"key":"BF02944350_CR8","doi-asserted-by":"crossref","unstructured":"Anonymous. Consensus Development Conference: treatment of primary breast cancer. Br. Med. J. 1986; 293: 946\u20137.","DOI":"10.1136\/bmj.293.6552.946"},{"key":"BF02944350_CR9","first-page":"1019","volume":"132","author":"C. S. B. Galasko","year":"1971","unstructured":"Galasko, C. S. B. The detection of skeletal metastases from carcinoma of the breast. Surg. Gynecol. Obstet. 1971; 132: 1019\u201324.","journal-title":"Surg. Gynecol. Obstet."},{"key":"BF02944350_CR10","unstructured":"Gilbert, H. A., Kagan, A. R. Metastases: incidence, detection and evaluation without histologic confirmation. Fundamental aspects of metastasis, ed Weiss: p. 385\u2013405. North-Holland, Amsterdam."},{"key":"BF02944350_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF01300197","volume":"32","author":"T. J. McGarrity","year":"1987","unstructured":"McGarrity, T. J., Samuels, T. N., Wilson, F. A. An analysis of imaging studies and liver function tests to detect hepatic neoplasia. Dig. Dis. Sci. 1987; 32: 1113\u20137.","journal-title":"Dig. Dis. Sci."},{"key":"BF02944350_CR12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.1979.03300110019019","volume":"242","author":"D. R. White","year":"1979","unstructured":"White, D. R., Maloney, III, J. J. et al. Serum alkaline phosphatase determination value in the staging of advanced breast cancer. JAMA 1979; 242: 1147\u20139.","journal-title":"JAMA"},{"key":"BF02944350_CR13","first-page":"9","volume":"74","author":"D. P. O\u2019Brien","year":"1992","unstructured":"O\u2019Brien, D. P., Horgan, P. G., Gough, D. B., Skehill, R., Grimes, H., Given, H. F. CA 15-3: a reliable indicator of metastatic bone disease in breast cancer patients. Ann. Roy. Coll. Surg. Engl. 1992; 74:9\u201312.","journal-title":"Ann. Roy. Coll. Surg. Engl."},{"key":"BF02944350_CR14","first-page":"210","volume":"180","author":"D. M. O\u2019Hanlon","year":"1995","unstructured":"O\u2019Hanlon, D. M., Kerin, M. J., Kent, P. J., Skehill, R., Maher, D., Grimes, H., Given, H. F. A prospective evaluation of CA 15-3 in stage I carcinoma of the breast. J. Am. Coll. Surg. 1995; 180: 210\u20132.","journal-title":"J. Am. Coll. Surg."},{"key":"BF02944350_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/172460089501000107","volume":"10","author":"E. C. Coveney","year":"1995","unstructured":"Coveney, E. C., Geraghty, J. G., Sherry, F., McDermott, E. W., Fennelly, J. J., O\u2019Higgins, N. J., Duffy, M. J. The clinical value of CEA and CA 15-3 in breast cancer management. Int. J. Biol. Markers 1995; 10: 35\u201341.","journal-title":"Int. J. Biol. Markers"},{"key":"BF02944350_CR16","doi-asserted-by":"crossref","first-page":"28314","DOI":"10.1002\/1097-0142(19921215)70:12<2831::AID-CNCR2820701218>3.0.CO;2-8","volume":"70","author":"J. G. Geraghty","year":"1992","unstructured":"Geraghty, J. G., Coveney, E. C., Sherry, F., O\u2019Higgins, N. J., Duffy, M. J. CA 15-3 in patients with locoregional and metastatic breast carcinoma. Cancer 1992; 70: 28314.","journal-title":"Cancer"},{"key":"BF02944350_CR17","first-page":"1597","volume":"4","author":"B. Iacopetta","year":"1998","unstructured":"Iacopetta, B., Grieu, F., Powell, B., Soong, R., McCaul, K., Seshadri, R. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer. Clin. Cancer Res. 1998; 4: 1597\u2013602.","journal-title":"Clin. Cancer Res."},{"key":"BF02944350_CR18","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1136\/bmj.309.6968.1573","volume":"309","author":"W. R. Miller","year":"1994","unstructured":"Miller, W. R., Elli, I. O., Sinsbury, J. R. C., Dixon, J. M. Prognostic Factors. ABC of breast diseases. BMJ 1994; 309: 1573\u201376.","journal-title":"BMJ"},{"key":"BF02944350_CR19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/clinchem\/44.6.1177","volume":"44","author":"M. J. Duffy","year":"1998","unstructured":"Duffy, M. J., Duggan, C., Mulcahy, H. E., McDermott, E. W., O\u2019Higgins, N. J. Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease. Clin. Chem. 1998; 44: 1177\u201383.","journal-title":"Clin. Chem."},{"key":"BF02944350_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000030025","volume":"19","author":"D. Nikolic-Vukosavljevic","year":"1998","unstructured":"Nikolic-Vukosavljevic, D., Grujic-Adanja, G., Nastic-Miric, D., Brankovic-Magic, M., Jovanovic, D., Polic, D., Mitrovic, L. Cathepsin D: association between TN-stage and steroid receptor status of breast carcinoma. Tumour Biol. 1998; 19: 329\u201334.","journal-title":"Tumour Biol."},{"key":"BF02944350_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02944236","volume":"166","author":"P. G. Horgan","year":"1997","unstructured":"Horgan, P. G., Byrne, J., O\u2019Donoghue, J., Mooney, E., Grimes, H., Given, H. F. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer. Ir. J. Med. Sci. 1997; 166: 215\u2013216.","journal-title":"Ir. J. Med. Sci."},{"key":"BF02944350_CR22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/1097-0142(19880301)61:5<1038::AID-CNCR2820610530>3.0.CO;2-Z","volume":"61","author":"S. Ciatto","year":"1988","unstructured":"Ciatto, S., Pacini, P., Azzini, V., Neri, A. et al. Preoperative staging of primary breast cancer. A Multicentre study. Cancer 1988; 61: 1038\u201340.","journal-title":"Cancer"},{"key":"BF02944350_CR23","first-page":"1117","volume":"12","author":"G. Gasparini","year":"1998","unstructured":"Gasparini, G., Toi, M., Verderio, P., Ranieri, G., Dante, S., Bonoldi, E., Boracchi, P., Fanelli, M., Tominaga, T. Prognostic significance of P53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients. Int. J. Oncol. 1998; 12: 1117\u201325","journal-title":"Int. J. Oncol."},{"key":"BF02944350_CR24","first-page":"199","volume":"11","author":"R. W. Carlson","year":"1997","unstructured":"Carlson, R. W., Goldstein, L. J., Gradishar, W. J., Lichter, A. S., McCormick, B., Moe, R. E., Theriault, R. L. Update of the NCCN guidelines for treatment of breast cancer. Oncology 1997; 11: 199\u2013220.","journal-title":"Oncology"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02944350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02944350\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02944350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T18:52:23Z","timestamp":1632941543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02944350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["BF02944350"],"URL":"https:\/\/doi.org\/10.1007\/bf02944350","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}